Clinical trials
Colonic Neoplasms trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 7 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| GlaxoSmithKline | 2 |
| Göteborg University | 2 |
| Isofol Medical AB | 2 |
| Sahlgrenska University Hospital | 2 |
| Uppsala University | 2 |
| Agendia | 1 |
| Amgen | 1 |
| Ann-Sofie Backman | 1 |
| Anna Martling | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colonic Neoplasms | 35 |
| Colorectal Neoplasms | 12 |
| Rectal Neoplasms | 12 |
| Gastrointestinal Diseases | 3 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 3 |
| Anxiety Disorders | 2 |
| Breast Neoplasms | 2 |
| Digestive System Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
Trials
Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.